Table 2.

Drug classes of the whole population at baseline and follow‐up

	Baseline N(%)	Follow‐up N(%)	P (McNemar test)
ACE inhibitors	122 (29%)	155 (37%)	0.001
Angiotensin receptor blockers	116 (27%)	184 (44%)	<0.001
Beta‐blockers	94 (22%)	119 (28%)	0.0011
Calcium channel antagonist	134 (32%)	163 (39%)	0.0032
Alpha‐blockers	50 (12%)	55 (13%)	0.4751
Diuretics	130 (31%)	156 (37%)	0.0116
Statins	50 (12%)	92 (22%)	<0.001

Data are shown as number and percentage. Median follow‐up time was 3.85 y.

ACE, angiotensin‐converting enzyme.